Interventions for Maximizing Patient And Family Smoking Cessation Together
Key facts
- Who runs it
- Papworth Hospital NHS Foundation Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 231 people, planned
- Started
- 7 Jul 2025
- Expected to end
- Apr 2027
- Type of study
- Interventional
- Treatments tested
- Household member support
- Record updated
- 14 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Any inpatient aged 18 and above admitted to Papworth Hospital who smoke. (Smoking is described as using any tobacco products as defined by the TTD programme)
- Patient and household members must be eligible to join the TTD programme
- Patients must live in a household with other smokers
- Participants must live in Cambridgeshire and/or be registered with a GP Practice in the Cambridgeshire \& Peterborough Integrated Care System
Who cannot take part
- Pregnant individuals - Pregnant individuals who smoke are offered a differing pathway to the standard TTD programme
- Contraindications for NRT
- Any household member who smokes unwilling to participate
- Individuals already enrolled on smoking cessation programme
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This feasibility study evaluates the effectiveness of a household-based smoking cessation intervention for patients and their household members. Patients who smoke and live with household members who also smoke will be invited to participate in the Treating Tobacco Dependency (TTD) program at Royal Papworth Hospital. The study aims to assess whether providing support to both patients and their household members improves quit rates and reduces relapse risk.
Read full original descriptionShow less
Participants will receive nicotine replacement therapy (NRT) and behavioural support, with follow-up assessments at 28 days, 3 months, and 12 months after starting the program. This study will compare outcomes to historical data from patients who participated in the TTD program without household support.
The group in the trial
- Patients with household members supportTreatment being tested
Both the patients and the additional household members will be provided with Nicotine Replacement Therapy products and behavioural support. All participants will be followed up at 28 days, 3 months and 12 months post start Quit Date. The intervention in this study involves inviting household members of the patients, to participate in the Treating Tobacco Dependency program. The control group is patients without household members support. This is based on retrospective data of all patients who were admitted to Papworth Hospital and engaged with the Treating Tobacco Dependency Programme without any household members invited.
Treatment: Household member support
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 May 2026